España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Voyager Therapeutics
VYGR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.22
-0.04
-0.94%
At close: -
$4.32
0.10
2.37%
After Hours: 4:41 PM EDT
Get Report
Comment
Voyager Therapeutics (VYGR) Forecast
News
Earnings
Voyager Therapeutics (VYGR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Voyager Therapeutics (NASDAQ:VYGR) Stock
Voyager Therapeutics Stock (NASDAQ: VYGR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, February 11, 2025
Voyager Therapeutics Announced It Has Decided...
Benzinga Newsdesk
Monday, January 27, 2025
HC Wainwright & Co. Reiterates Buy on Voyager...
Benzinga Newsdesk
Monday, December 02, 2024
A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 5 Analysts
Benzinga Insights
Citigroup Initiates Coverage On Voyager Thera...
Benzinga Newsdesk
Wednesday, November 20, 2024
Voyager Selects Tau Silencing Gene Therapy De...
Benzinga Newsdesk
Thursday, November 14, 2024
Canaccord Genuity Maintains Buy on Voyager Th...
Benzinga Newsdesk
Voyager Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Voyager...
Benzinga Newsdesk
Tuesday, November 12, 2024
Voyager Therapeutics Q3 2024 GAAP EPS $(0.16)...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
Preview: Voyager Therapeutics's Earnings
Benzinga Insights
Thursday, October 24, 2024
HC Wainwright & Co. Reiterates Buy on Voyager...
Benzinga Newsdesk
Tuesday, October 22, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Wednesday, October 16, 2024
Voyager Therapeutics shares are trading highe...
Benzinga Newsdesk
In-Depth Examination Of 4 Analyst Recommendations For Voyager Therapeutics
Benzinga Insights
Leerink Partners Initiates Coverage On Voyage...
Benzinga Newsdesk
Monday, September 16, 2024
Voyager Says Joint Steering Committee With Co...
Benzinga Newsdesk
Thursday, September 05, 2024
Voyager Therapeutics Announces Novartis Licen...
Benzinga Newsdesk
Tuesday, August 20, 2024
HC Wainwright & Co. Reiterates Buy on Voyager...
Benzinga Newsdesk
Wednesday, August 07, 2024
Voyager Therapeutics shares are trading lower...
Benzinga Newsdesk
Wedbush Maintains Neutral on Voyager Therapeu...
Benzinga Newsdesk
Tuesday, August 06, 2024
Voyager Therapeutics Q2 2024 GAAP EPS $(0.18)...
Benzinga Newsdesk
Wednesday, July 31, 2024
What Analysts Are Saying About Voyager Therapeutics Stock
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Voyager...
Benzinga Newsdesk
Thursday, June 13, 2024
Voyager Therapeutics Taps Nathan Jorgensen of...
Benzinga Newsdesk
Thursday, May 16, 2024
HC Wainwright & Co. Reiterates Buy on Voyager...
Benzinga Newsdesk
Voyager Therapeutics Says First Participants ...
Benzinga Newsdesk
Wednesday, May 15, 2024
Oppenheimer Maintains Outperform on Voyager T...
Benzinga Newsdesk
Tuesday, May 14, 2024
Wedbush Maintains Neutral on Voyager Therapeu...
Benzinga Newsdesk
Monday, May 13, 2024
Voyager Therapeutics Reports Cash Position Of...
Benzinga Newsdesk
Voyager Therapeutics Q1 2024 GAAP EPS $(0.20)...
Benzinga Newsdesk
Wednesday, May 08, 2024
Voyager Therapeutics Presents Data for Second...
Benzinga Newsdesk
Friday, May 03, 2024
Puma Biotechnology's Q1 Earnings and Revenues Beat
Zacks
Monday, April 22, 2024
Voyager Therapeutics To Present Translational...
Benzinga Newsdesk
Tuesday, April 16, 2024
Selection Of The Development Candidate Trigge...
Benzinga Newsdesk
Voyager Therapeutics And Neurocrine Bioscienc...
Benzinga Newsdesk
Voyager Therapeutics And Neurocrine Bioscienc...
Benzinga Newsdesk
Tuesday, April 02, 2024
Voyager Therapeutics Said Co And CFO Peter P. Pfreundschuh Entered Into A Transition, Separation And Release Of Claims Agreement; Pfreundschuh Resigned From His Position AsCFO Effective On April 12, 2024
Charles Gross
Tuesday, March 26, 2024
Voyager Therapeutics shares are trading highe...
Benzinga Newsdesk
Guggenheim Initiates Coverage On Voyager Ther...
Benzinga Newsdesk
Tuesday, March 19, 2024
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
Vandana Singh
Voyager Therapeutics shares are trading highe...
Benzinga Newsdesk
HC Wainwright & Co. Initiates Coverage On Voy...
Benzinga Newsdesk
Thursday, March 07, 2024
Citigroup Initiates Coverage On Voyager Thera...
Benzinga Newsdesk
Thursday, February 29, 2024
Voyager Therapeutics shares are trading lower...
Benzinga Newsdesk
Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge
Piero Cingari
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, February 28, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Voyager Therapeutics: Q4 Earnings Insights
Benzinga Insights
Voyager Therapeutics Q4 2023 GAAP EPS $1.25 B...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
